INDIAGLYCO
India Glycols share price & financials
- Price
- ₹957.75
- Market cap
- ₹7.4k Cr
- Sector
- Fast Moving Consumer Goods
- Calls analysed
- 8
India Glycols Limited Q1 FY27
What went well
- Net revenue of INR1,130 crores, up 9% YoY.
- Record EBITDA of INR170 crores, up 13% YoY, with EBITDA margin at 15.0% (vs 14.3% in Q1 FY26).
- PAT up 32% YoY.
What to watch
- Raw material availability and pricing volatility continue to be a challenge in Q2 for Ennature Bio Pharma.
- Performance chemicals business grew 40%, which was lower than targeted due to exports suffering and prohibitively expensive raw materials.
What India Glycols Limited does
India Glycols manufactures bio-based glycols, glycol ethers, bio-polymers, specialty chemicals and industrial gases via a renewable, molasses-based agro route, and operates grain-based ethanol distilleries that feed its potable spirits and biofuel businesses. Its Potable Spirits division distills, bottles and sells country liquor and Indian Made Foreign Liquor (IMFL) under its own brands and as manufacturing/bottling partner for Bacardi and Amrut Distilleries. The Ennature Biopharma division extracts plant-based active pharmaceutical ingredients (APIs), branded nutraceutical ingredients and nicotine derivatives for pharmaceutical, nutraceutical and food & beverage customers. The Bio-Fuel business supplies ethanol to oil marketing companies from its grain-based distilleries.
Segments
- Bio-based Specialties & Performance Chemicals (BSPC)
- Potable Spirits (PS)
- Ennature Biopharma (EB)
- Bio-Fuel (BF)
- Manufacturing facilities
- 3 integrated facilities at Kashipur, Gorakhpur and Dehradun, spread over ~360 acres
- Grain-based distillery capacity (Kashipur)
- 500 KLPD installed capacity
- Bio-fuel ethanol plant capacity (Kashipur)
- 590 KLPD installed capacity
- Distillery + ethanol capacity (Gorakhpur, combined)
- 310 KLPD installed capacity
- New specialty chemicals plant capacity (Kashipur)
- 7,500 MT per annum
- Export footprint
- Exports to 40+ countries
Guidance record · Q1 FY27
what the last two calls moved 28 tracked 7 delivered 5 missed 16 open- Long Term Debt Repayment (FY26) delivered said Q2 FY25 Promised: INR 200 crores next year Q1 FY27: Target period has passed.
- Long Term Debt at FY25 end missed said Q2 FY25 Promised: around INR 1,200 crores by March 31st Q1 FY27: Target period has passed.
- Chemicals Margin Retention at risk said Q3 FY26 Promised: Retain percentage margin Q1 FY27: The demerged Chemicals entity reported an EBITDA margin of 11.6%. This is below the Q3 FY26 EBIT margin benchmark of 12.8%, indicating pressure on margins.
All 28 tracked — every revision, and every one management stopped mentioning.
Open the guidance ledgerQuarterly results
Q1 FY27: revenue up 8.7%, net profit up 32.9% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 961 | 975 | 863 | 1,040 | 1,092 +14% | 1,102 +13% | 976 +13% | 1,130 +9% |
| EBITDA | 116 | 124 | 146 | 150 | 158 +36% | 175 +41% | 166 +14% | 170 +13% |
| Net profit | 50 | 57 | 64 | 73 | 65 +30% | 68 +19% | 87 +36% | 97 +33% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −65.7% 1Y
1Y: ₹858.65 on 10 Sept 2025 → ₹294.9. High ₹1,203.3 (27 Aug 2026), low ₹236.2 (2 Sept 2026).
How the price took the results
close before → close after
- Q1 FY27
- +0.5%
- 14 Aug
- Q4 FY26
- −1.0%
- 18 May
- Q3 FY26
- −1.5%
- 12 Feb
- Q2 FY26
- −1.0%
- 18 Nov
The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.
Financials, as filed
Revenue grew 16.7% a year over 3 years, FY23 to FY26. Operating margin widened to 15.4%.
| Year ending | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | ₹2.7k Cr | ₹3.3k Cr | ₹3.8k Cr | ₹4.2k Cr |
| Operating profit | ₹294 Cr | ₹403 Cr | ₹512 Cr | ₹649 Cr |
| Operating margin | 11.1% | 12.2% | 13.6% | 15.4% |
| Interest | ₹99 Cr | ₹121 Cr | ₹165 Cr | ₹167 Cr |
| Depreciation | ₹93 Cr | ₹101 Cr | ₹116 Cr | ₹154 Cr |
| Net profit | ₹142 Cr | ₹173 Cr | ₹231 Cr | ₹293 Cr |
| Net margin | 5.4% | 5.3% | 6.1% | 7.0% |
| Cash from operations | ₹326 Cr | ₹439 Cr | ₹362 Cr | ₹769 Cr |
| Free cash flow | ₹-109 Cr | ₹-103 Cr | ₹-391 Cr | ₹-47 Cr |
| ROCE | 8.0% | 11.0% | 12.0% | 12.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹31 Cr | ₹31 Cr | ₹31 Cr | ₹31 Cr | ₹31 Cr | ₹34 Cr |
| Reserves | ₹1.1k Cr | ₹1.8k Cr | ₹1.9k Cr | ₹2.0k Cr | ₹2.4k Cr | ₹2.9k Cr |
| Borrowings | ₹1.1k Cr | ₹1.0k Cr | ₹1.1k Cr | ₹1.3k Cr | ₹2.1k Cr | ₹1.7k Cr |
| Other liabilities | ₹1.8k Cr | ₹1.8k Cr | ₹1.8k Cr | ₹2.2k Cr | ₹1.7k Cr | ₹1.9k Cr |
| Total liabilities | ₹4.1k Cr | ₹4.6k Cr | ₹4.9k Cr | ₹5.6k Cr | ₹6.2k Cr | ₹6.5k Cr |
| Fixed assets | ₹2.2k Cr | ₹2.3k Cr | ₹2.7k Cr | ₹3.2k Cr | ₹3.8k Cr | ₹4.6k Cr |
| Capital work in progress | ₹126 Cr | ₹243 Cr | ₹125 Cr | ₹84 Cr | ₹267 Cr | ₹37 Cr |
| Investments | ₹27 Cr | ₹336 Cr | ₹318 Cr | ₹335 Cr | ₹411 Cr | ₹389 Cr |
| Other assets | ₹1.8k Cr | ₹1.7k Cr | ₹1.7k Cr | ₹2.0k Cr | ₹1.7k Cr | ₹1.5k Cr |
| Total assets | ₹4.1k Cr | ₹4.6k Cr | ₹4.9k Cr | ₹5.6k Cr | ₹6.2k Cr | ₹6.5k Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, DIIs added +3.82 pp while promoters trimmed −1.39 pp. The shareholder count shrank 4% to 52,968.
- Promoters
- 59.6%
- FIIs
- 2.2%
- DIIs
- 5.2%
- Public
- 32.9%
Since Jun 2025
- DIIs +3.82 pp
- Promoters −1.39 pp
- Public −1.24 pp
How it drifted, 12 quarters
Over this window DIIs went from 0.1% to 5.2% — +5.2 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 61.0%, FIIs 1.3%, DIIs 0.1%, Public 37.6%.Dec '23: Promoters 61.0%, FIIs 1.6%, DIIs 0.1%, Public 37.3%.Mar '24: Promoters 61.0%, FIIs 1.8%, DIIs 0.1%, Public 37.1%.Jun '24: Promoters 61.0%, FIIs 1.8%, DIIs 0.1%, Public 37.1%.Sep '24: Promoters 61.0%, FIIs 2.9%, DIIs 1.9%, Public 34.1%.Dec '24: Promoters 61.0%, FIIs 2.4%, DIIs 2.0%, Public 34.5%.Mar '25: Promoters 61.0%, FIIs 2.2%, DIIs 0.9%, Public 35.8%.Jun '25: Promoters 61.0%, FIIs 3.4%, DIIs 1.4%, Public 34.1%.Sep '25: Promoters 61.0%, FIIs 2.6%, DIIs 1.3%, Public 35.0%.Dec '25: Promoters 59.6%, FIIs 2.4%, DIIs 5.2%, Public 32.7%.Mar '26: Promoters 59.6%, FIIs 2.3%, DIIs 5.2%, Public 32.9%.Jun '26: Promoters 59.6%, FIIs 2.2%, DIIs 5.2%, Public 32.9%.
Who is on the register
Named in the Jun 2026 filing
Every holder of India Glycols Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Kashipur Holdings Limited | 49.77% | unchanged |
| Executors To The Estate Of Late Sajani Devi Bhartia | 6.27% | unchanged |
| Puneet Bhatia | 1.77% | unchanged |
| 360 One Pipe Fund Mutual fund | 1.69% | unchanged |
| Investor Education and Protection Fund | 1.40% | unchanged |
| Uma Shankar Bhartia | 1.34% | unchanged |
| Sukhvarsha Distributors Pvt. Ltd. | 1.08% | unchanged |
| Negen Undiscovered Value Fund AIF | 1.04% | unchanged |
| Jayshree Bhartia | 0.68% | unchanged |
| Pooja Jhaver | 0.29% | unchanged |
| Hindustan Wires Limited | 0.19% | unchanged |
| Facit Commosales Private Limited | 0.00% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
What the price assumes
AttractiveTo justify its price of ₹295, this stock must grow earnings at -8% every year for 7 years. Our analysis caps realistic growth at ~31%. At that growth it is worth ₹2251 — upside of 663%.
- Growth the price implies
- -7.5% a year
- for 7 years, fading to 4%
- It has actually compounded at
- 27.3% a year
- net profit, FY23–FY26 · EPS 31.0%
- The gap
- -0.4 pp
- 663% downside if it only repeats history
All earnings calls (8)
Read the Q1 FY27 call →Learn to analyse India Glycols Limited
Guides on how to read this kind of business and the numbers that matter.